Severe malaria is associated with parasite binding to endothelial protein C receptor

Louise Turner1, Thomas Lavstsen, Sanne S Berger

  • 1Centre for Medical Parasitology, Department of International Health, Immunology & Microbiology, University of Copenhagen and Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark. lturner@sund.ku.dk

Nature
|June 7, 2013
PubMed

Insights

Severe malaria involves Plasmodium falciparum-infected red blood cells sticking to blood vessels. Researchers found that the endothelial protein C receptor (EPCR) is the binding site for specific malaria proteins, impacting disease severity.

Area of Science:

  • Malariology
  • Immunology
  • Vascular Biology

Background:

  • Severe childhood malaria, causing ~1 million deaths annually, stems from Plasmodium falciparum-infected erythrocyte sequestration.
  • Sequestration relies on interactions between P. falciparum erythrocyte membrane protein 1 (PfEMP1) and endothelial receptors.
  • Specific PfEMP1 subtypes (DC8 and DC13) are linked to severe malaria, but their receptor was unidentified.

Purpose of the Study:

  • To identify the endothelial receptor for DC8 and DC13 PfEMP1 variants.
  • To elucidate the molecular mechanism of PfEMP1-EPCR interaction in severe malaria pathogenesis.

Main Methods:

  • Protein-protein interaction studies to identify the PfEMP1 receptor.
  • Analysis of PfEMP1 binding domains (CIDRα1) and their interaction with EPCR.
  • Investigating the functional consequences of PfEMP1 binding on protein C pathway.

Main Results:

  • Endothelial protein C receptor (EPCR) identified as the receptor for DC8 and DC13 PfEMP1.
  • The cysteine-rich interdomain region (CIDRα1) of these PfEMP1 variants mediates EPCR binding.
  • PfEMP1 binding to EPCR inhibits protein C binding, potentially disrupting anticoagulation and cytoprotective pathways.

Conclusions:

  • PfEMP1 from severe malaria parasites binds to EPCR, a key receptor in protein C-mediated cytoprotection and anticoagulation.
  • This interaction links parasite adhesion to a critical host pathway, offering insights into severe malaria pathogenesis.
  • Understanding this mechanism may guide the development of novel therapeutic strategies against severe malaria.

Related Concept Videos

Symbiosis00:58

Symbiosis

Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
Drug Binding to Blood Components01:30

Drug Binding to Blood Components

When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
Diversity of Protists II01:27

Diversity of Protists II

Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...